John Barry Egan, Ph.D

Affiliations: 
University of Adelaide, Adelaide, South Australia, Australia 
Area:
phage, bacterial genetics
Google:
"John Egan"
Mean distance: 10.51
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Bryce AH, Egan JB, Smadbeck JB, et al. (2019) Shared and unique genomic structural variants of different histological components within testicular germ cell tumours identified with mate pair sequencing. Scientific Reports. 9: 3586
Farooq M, Egan JB, McDonald B, et al. (2018) Detection of copy number aberrations in cholangiocarcinoma using shallow whole genome sequencing of plasma DNA. Journal of Clinical Oncology. 36: 293-293
Egan JB, Marks DL, Hogenson TL, et al. (2017) Molecular Modeling and Functional Analysis of Exome Sequencing-Derived Variants of Unknown Significance Identify a Novel, Constitutively Active FGFR2 Mutant in Cholangiocarcinoma. Jco Precision Oncology. 2017
Yokoda R, Nagalo BM, Arora M, et al. (2017) Oncolytic virotherapy in upper gastrointestinal tract cancers. Oncolytic Virotherapy. 7: 13-24
Yokoda R, Nagalo BM, Vernon B, et al. (2017) Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effect. Oncolytic Virotherapy. 6: 39-49
Bryce AH, Egan JB, Borad MJ, et al. (2017) Experience with precision genomics and tumor board, indicates frequent target identification, but barriers to delivery. Oncotarget. 27145-27154
Myers CE, Hoelzinger DB, Truong TN, et al. (2017) Chemotherapy can induce weight normalization of morbidly obese mice despite undiminished ingestion of high fat diet. Oncotarget
Bennani NN, Ansell SM, Witzig TE, et al. (2017) Clinical utility of molecular testing to select therapy in relapsed/refractory non-Hodgkin lymphoma: Mayo Clinic Center for Individualized Medicine experience. Journal of Clinical Oncology. 35: 11571-11571
Bryce AH, Borad MJ, Egan JB, et al. (2016) Comprehensive Genomic Analysis of Metastatic Mucinous Urethral Adenocarcinoma Guides Precision Oncology Treatment: Targetable EGFR Amplification Leading to Successful Treatment With Erlotinib. Clinical Genitourinary Cancer
Borad MJ, Egan JB, Condjella RM, et al. (2016) Clinical Implementation of Integrated Genomic Profiling in Patients with Advanced Cancers. Scientific Reports. 6: 25
See more...